Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Global Clean Energy ETF (ICLN) vs Nuwellis Inc (NUWE) Price & Performance

iShares Global Clean Energy ETFTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

iShares Global Clean Energy ETF vs Nuwellis Inc — how do they compare? iShares Global Clean Energy ETF trades at $17.28 (market cap $2.30B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: iShares Global Clean Energy ETF is far larger — about 1045.5× Nuwellis Inc's market cap, and iShares Global Clean Energy ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Global Clean Energy ETF for 87 Days and Nuwellis Inc for 26 Days on average.

ICLNNUWE
Market Cap
$2.30B$2.20M
Volume
3,661,617121,544
52-Week High
$23.75$146.65
52-Week Low
$15.78$0.68
Typical Hold Time
87 Days26 Days
Sector
—Health
Enterprise Value
—-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Global Clean Energy ETF

ICLN trades at $17.31, down 1.31% with a bearish technical signal from moving averages. The ETF faces volatility with clean energy exposure showing deeper drawdowns compared to traditional energy peers. Recent news highlights competitive pressure from fossil fuel ETFs delivering stronger returns and lower fees, though geopolitical tensions are accelerating global renewable energy adoption.

The outlook remains challenged by high expense ratios and sector volatility, but long-term growth potential exists from global energy transition trends. Key risks include competitive pressure from traditional energy and execution challenges in renewable adoption timelines.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ICLN
100% Buy0% Sell
Avg holding period · 87 Days
NUWE
40% Buy60% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About iShares Global Clean Energy ETF

The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.

Read more on ICLN →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →